1. Martin DH, Dews PB: On the control of cyclical patterns of responding: The effects of interpolated food and brief periods of general anesthesia. Comm in Behav Biol, Part A. 1:69-73, 1968.
2. Martin DH: Classification of epidemic Venezuelan equine encephalomyelitis isolates (Discussion), "Venezuela Equine Encephalitis," Pan American Health Organization, 1972, Publication 234, Washington, pp 93-95.
3. Eddy GA, Martin DH, Reeves WC, Johnson KM: Field studies of attenuated Venezuelan encephalomyelitis vaccine. Infect Immun 5:160-163, 1972.
4. Martin DH, Eddy GA, Studia WD, Reeves WC, Newhouse VJ, Johnson KM: An epidemiological study of Venezuelan equine encephalitis in Costa Rica, 1970. Am J Epidemiol 95:565-578, 1972.
5. Eddy GA, Martin DH, Johnson KM: Epidemiology of the Venezuelan equine encephalitis virus complex. Proceedings of the Third International Conference on Equine Infectious Diseases," Paris, 1972, pp 126-145 (S. Karger Press, Basel, Switzerland).
6. Martin DH, Chaniotis BA, Tesh RB: Host preferences of Deinocerites pseudes Dyar and Knab. J Med Ent 10:206-208, 1972.
7. Johnson KM, Martin DH: Venzuelan equine encephalitis. Adv Vet Science Comp Med 18:79-116, 1974.
8. Dietz WH, Alvarez O Jr, Martin DH, Walton TE, Ackerman LF, Johnson KM: Enzootic and epizootic Venezuelan equine encephalomyeltis virus in horses infected by peripheral and intrathecal routes. J Infect Dis 137:227, March 1978.
9. Holmes KK, Martin DH: Advances in the management of sexually transmitted diseases. Postgraduate Medicine 64:121-136, 1978.
10. Stamm WE, Counts GW, Wagner KF, Martin DH, Gregory D, McKevitt M, Turck M, Holmes KK: Antimicrobial prophylaxis of recurrent urinary tract infections: A double-blind, placebo controlled trial. Ann Intern Med 92:770-775, 1980.
11. Wager GP, Martin DH, Koutsky L. Eschenbach DA, Daling JR, Chiang WT, Alexander ER, Holmes KK: Puerperal infectious morbidity: Relationship to route of delivery and to antepartum Chlamydia trachomatis infection. Am J Obstet Gynecol 138:1028-1033, 1980.
12. Brunham RC, Martin DH, Kuo C, Wang S, Stevens CE, Hubbard T, Holmes KK: Cellular immune response during uncomplicated genital infection with Chlamydia trachomatis in humans. Infect Immun 34:98-104, 1981.
13. Martin DH, Koutsky L, Eschenbach DA, Daling JR, Alexander ER, Benedetti JK, Holmes KK: Prematurity and perinatal mortality in pregnancies complicated by antepartum maternal Chlamydia trachomatis infections. JAMA 247:1585- 1588, 1982.
14. Martin DH, Dietz WH, Alvarez O, Johnson KM: Epidemiological significance of Venezuelan equine encephalomyelitis virus. In vitro markers. Am J Trop Med 31:561-568, 1982.
15. Brunham RC, Martin DH, Hubbard TW, Kuo CC, Critchlow CW, Cles LD, Eschenbach DA, Holmes KK: Suppression of the lymphocyte transformation response to microbial antigens and to phytohemagglutinin during pregnancy. J Clin Invest 72:1629-1638, 1983.
16. Martin DH, Pollock S, Kuo C-C, Wang S-P, Brunham RC, Holmes KK: Chlamydia trachomatis infections in men with Reiter's syndrome. Ann Intern Med 100:207-213, 1984.
17. Sanders CV, Marier RM, Aldridge KE, Derks FW, Martin DH: The safety and effectiveness of ticarcillin/clavulanic acid in the treatment of community-acquired pyelonephritis in adult females. Am J Med, 79(S5B):96-101, 1985.
18. Martin DH, Pastorek JH, Faro S: In vitro and in vivo activity of parenterally administered beta lactam antibiotics against Chlamydia trachomatis. Sex Transm Dis, 13:81-87, 1986.
19. Karam GH, Martin, DH, Flotte TR, Bonnarens FD, Mroczkowski TF, Johnson WD: Asymptomatic Chlamydia trachomatis infections among sexually active men. J Inf Dis, 154:900-903, 1986.
20. Kumar P, Pearson JE, Martin DH, Leech SH, Buisseret PD, Bezbak HC, Gonzalez FM, Roger Jr, Streicher HZ, Saxinger WC: Transmission of acquired immune deficiency syndrome (AIDS) by transplantation of a living relayed renal allograft. Ann Intern Med, 106:244-245, 1987.
21. Cosmo LY, Risi G, Nelson S, Subramanian P, Martin DH, Haponic EF: Fatal hemoptysis in acute bacterial endocarditis. Am Rev Resp Dis, 137:1223-26, 1988.
22. Schachter J, Martin DH: Failure of multiple passage to increase chlamydial recovery. J Clin Microb, 25:1851-1853, 1987.
23. Risi GF, Silberman JA, Martin DH, Cohen C: The development of a DNA probe for detection of Mycoplasma genitalium in clinical specimens. Molecular and Cellular Probes, 2:327-335, 1988
24. Pastorek JG, Mroczkowski TF, Martin DH: Fine tuning the fluorescent antibody test for chlamydial infections in pregnancy. Obstet and Gyn. 72:957-960, 1988.
25. Sheppard A, Cammarata C, Martin DH: Comparison of different medium bases for the semiquantitative isolation of anaerobes from vaginal secretions. J Clin Micro. 28:455-457, 1990.
26. Jones RB, Van Der Pol B, Martin DH, and Shepard MK. Partial characterization of Chlamydia trachomatis isolates resistant to multiple antibiotics. J Infect Dis. 162:1309-1315, 1990.
27. Carey JC, Blackwelder WC, Nugent RP, Matteson MA, Rao VA, Eschenbach DA, Lee MLF,Rettig PJ, Regan JA, Geromanos KL, Martin DH, Pastorek JG, Gibbs RS, Lipscomb KA, and the Vaginal Infections and Prematurity Study Group. Antepartum cultures for Ureaplasma urealyticum are not useful in predicting pregnancy outcome. Am J Obstet Gynecol. 164:728-733, 1991.
28. Eschenbach DA, Nugent RP, Rao VA, Cotch MF, Gibbs RS, Lipscomb KA, Martin DH, Pastorek JG, Rettig PJ, Carey JC, Regan JA, Geromanos KL, Lee MLF, Poole WK, Edelman R, and the Vaginal Infections and Prematurity Study Group. A randomized placebo-controlled trial of erthromycin for the treatment of Ureaplasma urealyticum to prevent premature delivery. Am J Obstet Gynecol 164:734-742, 1991.
29. Seliborska Z, Mroczkowski TF, Martin D, Moore L. Immunotyp Chlamydia trachomatis a obraz kliniczny NGU u mezczyzn i zapalenia szyjki macicy u kobiet. Przegl. Derm. 77(4):272-275, 1990.
30. Martin DH, Pearson JE, Kumar P, Leech SH, Saxinger C, Streicher HZ: Elevated B-2 microglobulin levels associated with acquired immune dificiency sydrome (AIDS) in a renal allograft recipient. J Acquir Immune Deficiency Syndromes 4:118-121, 1991.
31. Cotch MF, Pastorek JG, Nugent RP, Yerg DE, Martin DH, Eschenbach DA, for the Vaginal Infections and Prematurity Study Group. Demographic and behavioral predictors of Trichomonas vaginalis infection among pregnant women. Obstet Gynecol 78:1087-1092, 1991.
32. Martin DH, Mroczkowski TF, Dalu AZ, McCarty J, Jones RB, Hopkins SJ, Johnston RB and the Azithromycin for Chlamydial Infections Study Group. Azithromycin in the treatment of chlamydial urethritis/cervicitis: A multicenter comparative trial. New Engl J Med 327:921-925, 1992.
33. Moncada J, Schachter J, Bolan G, Nathan J, Shafer M-A, Clark A, Schwebke J, Stamm W, Mroczkowski T, Seliborska Z, and Martin DH. Evaluation of Syva's enzyme immunoassay for the detection of Chlamydia trachomatis in urogenital specimens. Diagn Microbiol Infect Dis 15:663-668, 1992.
34. Ernst AA, Martin DH. High syphilis rates among cocaine abusers identified in an emergency department. Sex Transm Dis. 20:66-69, 1993.
35. Johnson SR, Martin DH, Cammarata C, and Morse SA. Development of a polymerase chain reaction assay for the detection of Haemophilus ducreyi. Sex Transm Dis. 21:13-23, 1994.
36. Aldridge KE, Cammarata CL, Martin DH. Comparison of the invitro activities of various parenteral and oral antimicrobial agents against endemic Haemophilus ducreyi. Antimicrob Agents Chemother 37;1986 1988, 1993.
37. Mroczkowski TF, Millikan LE, Martin DH, Leonik KJ. Treatment of gonococcal infections with a single 250 mg intramuscular injection of trospectomycin sulphate vs ceftriaxone sodium. Drugs Exptl Clin Res. 19(1):41-46, 1993.
38. Hook EW, III, Jones RB, Martin DH, Bolan GA, Mroczkowski TF, Neumann TM, Haag JJ, Echols R. A comparison of ciprofloxacin and ceftriaxone as a single dose therapy for uncomplicated gonorrhea in women. Antimicrob Agents Chemother 37:1670-1673, 1993.
39. Martin DH and DiCarlo RP. Recent changes in the epidemiology of genital ulcer disease in the United States: The crack cocaine connection. Sex Transm Dis 21(Suppl):S76-S80, 1994.
40. Handsfield HH, Dalu ZA, Martin DH, Douglas JM Jr., McCarty JM, Johnson RB, and the Azithromycin Gonorrhea Study Group. Multicenter trial of single-dose azithromycin versus ceftriaxone in the treatment of uncomplicated gonorrhea. Sex Transm Dis 21(2):107-111, 1994.
41. Johnson SR, Martin DH, Cammarata C, and Morse SA. Alterations in sample preparation increase sensitivity of PCR assay for diagnosis of chancroid. J Clin Microbiol 33:1036-1038, 1995.
42. DiCarlo RP, Armentor BS, and Martin DH. Chancroid epidemiology in New Orleans men. J Infect Dis 172:446-452, 1995.
43. Ernest AA, Farley TA, Martin DH. Screening and empiric treatment of syphilis and related HIV rates in an inner-city emergency department. Acad Emerg Med2:765-772;1995.
44. Martin DH, Sargent SJ, Wendel GD, McCormack WM, Spier NA, Johnson RB. Comparison of azithromycin and ceftriaxone for the treatment of chancroid. Clin Infect Dis 21:409-414, 1995.
45. Stamm WE, Hicks CB, Martin DH, et al. Azithromycin for empirical treatment of nongonococcal urethritis syndrome in men. A randomized double blind study. JAMA 274:545-549, 1995.
46. Hillier SL, Nugent RP, Eschenbach DA, Krohn JA, Gibbs RS, Martin DH, et al for the Vaginal Infections and Prematurity Study Group. Association between bacterial vaginosis and preterm delivery of a low-birth weight infant. N Engl J Med 333;1737-1742, 1995.
47. Ernst AA, Marvez-Valls E, Martin DH. Incision and drainage versus aspiration of fluctuant buboes in the emergency department during an epidemic of chancroid. Sex Transm Dis 22(4)217-220, 1995
48. Dougherty SH, Sirinek KR, Schauer PR, Fink MP, Fabian TC, Martin DH, Wiedermann B. Ticarcillin/clavulanate compared with clindamycin/gentamicin (with or without ampicillin) for the Treatment of intra-abdominal infections in pediatric and adult patients. American Surgeon 61(4):297-303, 1995.
49. Regan JA, Klebanoff MA, Nugent RP, Eschenbach DA, Blackwelder WC, Lou Y, Gibbs RS, Rettig PJ, Martin DH, and Edelman R for the VIP Study Group. Colonization with group B streptococci in pregnancy and adverse outcome. Am J Obstet Gynecol 174:1354-1360, 1996.
50. Holmes KK, Johnson DW, Kvale PA, Halverson CW, Keys TF, Martin DH. Impact of a gonorrhea control program, including selective mass treatment, in female sex workers. J Infect Dis 174(Suppl 2):S230, 1996
51. Orle KA, Gates CA, Martin DH, et al. Simultaneous PCR detection of Haemophilus ducreyi, Treponema pallidum, and herpes simplex virus type 1 and 2 from genital ulcers. J Clin Microbiol 34:49-54, 1996.
52. Pastorek J, Cotch MF, Martin D, Eschenbach D for the Vatinal Infections and Prematurity Study Group. Clinical and microbiological correlates of trichomoniasis in pregnancy. Clin Infect Dis 23:1075-1080, 1996.
53. Butt, A. A., J. Figueroa, et al. (1997). "Ocular infection caused by three unusual marine organisms." Clin Infect Dis 24(4): 740.
54. Cotch, M. F., J. G. Pastorek, 2nd, et al. (1997). "Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group." Sex Transm Dis 24(6): 353-60.
55. DiCarlo, R. P. and D. H. Martin (1997). "The clinical diagnosis of genital ulcer disease in men." Clin Infect Dis 25(2): 292-8.
56. Irwin, D. E., J. C. Thomas, et al. (1997). "Self-treatment patterns among clients attending sexually transmitted disease clinics and the effects of self-treatment on STD symptom duration. The Study Group." Sex Transm Dis 24(6): 372-7.
57. Knoebel, E., P. Vijayagopal, et al. (1997). "In vitro infection of smooth muscle cells by Chlamydia pneumoniae." Infect Immun 65(2): 503-6.54.
Martin DH, Jones RB, Johnson RB. A phase II study of trovafloxacin for the treatment of Chlamydia trachomatis infections. J Antimicrob Chemother. (In press)
59. Beltrami, J. F., T. A. Farley, et al. (1998). "Evaluation of the Gen-Probe PACE 2 assay for the detection of asymptomatic Chlamydia trachomatis and Neisseria gonorrhoeae infections in male arrestees." Sex Transm Dis 25(10): 501-4.
60. Clark, R. A., D. H. Martin, et al. (1998). "The impact of human immunodeficiency virus disease on academic health centers." Am J Med 105(2): 87-90.
61. Cohen, D. A., M. Nsuami, et al. (1998). "A school-based Chlamydia control program using DNA amplification technology." Pediatrics 101(1): E1.
62. Kissinger, P., R. Brown, et al. (1998). "Effectiveness of patient delivered partner medication for preventing recurrent Chlamydia trachomatis." Sex Transm Infect 74(5): 331-3.
63. McCormack, W. M., D. H. Martin, et al. (1998). "Daily oral grepafloxacin vs. twice daily oral doxycycline in the treatment of Chlamydia trachomatis endocervical infection." Infect Dis Obstet Gynecol 6(3): 109-15.58.
Cohen, D. A., M. Nsuami, et al. (1999). "School-based screening for sexually-transmitted diseases." J La State Med Soc 151(12): 617-21.
Cohen, D. A., M. Nsuami, et al. (1999). "Repeated school-based screening for sexually transmitted diseases: a feasible strategy for reaching adolescents." Pediatrics 104(6): 1281-5.
Hagensee, M. E., J. Slavinsky, 3rd, et al. (1999). "Seroprevalence of human papillomavirus type 16 in pregnant women." Obstet Gynecol 94(5 Pt 1): 653-8.
Haydock, A. K., D. H. Martin, et al. (1999). "Molecular characterization of Haemophilus ducreyi strains from Jackson, Mississippi, and New Orleans, Louisiana." J Infect Dis 179(6): 1423-32.
Irwin, D. E., J. C. Thomas, et al. (1999). "Self-reported sexual activity and condom use among symptomatic clients attending STD clinics." Sex Transm Dis 26(5): 286-90.
Kissinger, P., J. Rice, et al. (1999). "Application of computer-assisted interviews to sexual behavior research." Am J Epidemiol 149(10): 950-4.
Martin, D. H., R. B. Jones, et al. (1999). "A phase-II study of trovafloxacin for the treatment of Chlamydia trachomatis infections." Sex Transm Dis 26(7): 369-73.
McCormack, W. M., Z. A. Dalu, et al. (1999). "Double-blind comparison of trovafloxacin and doxycycline in the treatment of uncomplicated Chlamydial urethritis and cervicitis. Trovafloxacin Chlamydial Urethritis/Cervicitis Study Group." Sex Transm Dis 26(9): 531-6.
Johnson, R. E., T. A. Green, et al. (2000). "Evaluation of nucleic acid amplification tests as reference tests for Chlamydia trachomatis infections in asymptomatic men." J Clin Microbiol 38(12): 4382-6.
Martin, D. H. (2000). "Preventing Chlamydia trachomatis Infections: A Changing Paradigm." Curr Infect Dis Rep 2(1): 7-83.
Martin, D. H., C. Cammarata, et al. (2000). "Multicenter evaluation of AMPLICOR and automated COBAS AMPLICOR CT/NG tests for Neisseria gonorrhoeae." J Clin Microbiol 38(10): 3544-9.
Miller, J. M. and D. H. Martin (2000). "Treatment of Chlamydia trachomatis infections in pregnant women." Drugs 60(3): 597-605.
Van Der Pol, B., T. C. Quinn, et al. (2000). "Multicenter evaluation of the AMPLICOR and automated COBAS AMPLICOR CT/NG tests for detection of Chlamydia trachomatis." J Clin Microbiol 38(3): 1105-12.
Stoner, B. P., J. M. Douglas, Jr., et al. (2001). "Single-dose gatifloxacin compared with ofloxacin for the treatment of uncomplicated gonorrhea: a randomized, double-blind, multicenter trial." Sex Transm Dis 28(3): 136-42.
Van Der Pol, B., D. H. Martin, et al. (2001). "Enhancing the specificity of the COBAS AMPLICOR CT/NG test for Neisseria gonorrhoeae by retesting specimens with equivocal results." J Clin Microbiol 39(9): 3092-8.
Butt AA, Michaels S, Greer D, Clark R, Kissinger PJ, Martin
DH. Serum LDH levels as a clue to the diagnosis of histoplasmosis. The AIDS
Reader 12:317-321, 2002.
Black CM., Marrazzo J, Johnson RE, Hook EW, Jones RB, Green
TA, Schachter J, Stamm WE, Bolan G, St. Louis ME, Martin DH. Head-to-head
multicenter comparison of DNA probe and nucleic acid amplification tests for
Chlamydia trachomatis in women with use of an improved reference standard. J Clin Micro 40:3757-3763, 2002.
Hook EW III, Martin DH, Stephens J, Smith BS, and Smith K. A
randomized, comparative pilot study of azithromycin versus benzathine penicilln
G for treatment of early syphilis. Sex Transm Dis 29(8):486-490, 2002
Mena L, Wang, X,
Mroczkowski T.F., Martin DH. Mycoplasma genitalium infections in
asymptomatic men and men with urethritis attending the New Orleans sexually
transmitted diseases clinic. Clin Inf Dis 35:1167-1173, 2002.
Schillinger JA, Kissinger P, Calvet H, Whittington WLH, Ransom
RL, Sternberg MR, Berman SM, Kent CK, Martin DH, Oh MK, Handsfield HH, Golan G,
Markowitz LE, Fortenberry JD. Patient-delivered partner treatment with
azithromycin to prevent repeated Chlamydia trachomatis infection among women: A
randomized, controlled trial. Sex Transm Dis 30(1):49-56, 2003.
Cohen DA, Farley TA,, Taylor SN, Martin DH, Schuster M. When
and where do youth have sex? The potential role of adult supervision.
Pediatrics 110(1-6), 2002. [http://www.pediatrics.org/cgi/content/full/110/6/e66].
Gaydos CA, Quinn TC, Willis D, Weissfeld A, Hook EW, Martin
DH, Ferrero DV, Schachter J. Performance of the APTIMA Combo 2 assay for the
multiiplex detection of Chlamydia trachomatis and Neisseria gonorrhoeae in
female urine and endocervical swab specimens. J Clin Micro 41(1): 304-309, 2003
Schachter J, McCormack WM, Chernesky MA, Martin DH, Van Der
Pol B, Rice PA, Hook EW III, Stamm WE, Quinn TC, Chow, JM. Vaginal swabs are
appropriate specimens for the diagnosis of genital tract infection with
Chlamydia trachomatis. J Clin Microbiol 41(8):3784-3789, 2003.
Palmisano ME, Gaffga AM, Daigle J, Brinkman J, Mire K, Lenczyk
K, Martin DH, Hagensee ME. Detection of human papillomavirus DNA in
self-administered vaginal swabs as compared to cervical swabs. Int J STD AIDS
14:560-567, 2003.
Farley TA, Cohen DA, Kahn RH, Lolis S, Johnson G, Martin DH.
The acceptability and behavioral effects of antibiotic prophylaxis for syphilis
prevention Sex Transm Dis
30(11):844-849, 2003.
Ferris MJ, Masztal A, Aldridge KE, Fortenberry JD, Fidel PL Jr, and Martin DH. Association
of Atopobium vaginae, a recently described metronidazole resistant anaerobe,
with bacterial vaginosis. BMC Infectious Diseases 4(1):5, 2004.
Moncada J, Schachter J, Hook EW III, Ferrero D, Gaydos C,
Quinn TC, Willis D, Weissfeld A, Martin, DH. The effect of urine testing in
evaluations of the sensitivity of the Gen-Probe APTIMA® Combo 2 assay on
endocervical swabs for Chlamydia trachomatis and Neisseria gonorrhoeae. The
infected patient standard reduces sensitivity of single site evaluation. Sex
Transm Dis 31(5):273-277, 2004.
Millman KL, Black C, Johnson R, Stamm WE, Jones R, Hook E,
Martin DH, Bolan G, Tavaré S, and Dean D. Strain variation of Chlamydia
trachomatis for sexually transmitted infections in the United States: A
population-based genetic epidemiologic study. J Bacteriol 185(8):2457-2465,
2004.
Fidel Pl Jr, Barousse MM, Espinosa T, Ficarra M, Sturtevant J,
Martin DH, Quayle AJ, Dunlap K. An intravaginal live Candida challenge in
humans lead to new hypotheses for the immunopathogenesis of vulvovaginal
candidiasis. Infect Immun 72(5):2939-2946, 2004.
Nsuami M, Cammarata C, Brooks BN, Taylor SN, Martin DH.
Chlamydia and gonorrhea co-occurrence in a high school population. Sex Transm
Dis 31(7):424-427, 2004.
Ma L, Martin DH. Single nucleotide polymorphisms in the rRNA
operon and variable numbers of tandem repeats in the lipoprotein gene among
Mycoplasma genitalium clinical strains. J Clin Microbiol 42(10):4876-4878,
2004.
Martin DH, Nsuami M, Schachter J, Hook EW III, Ferrero D,
Quinn TC, Gaydos C. The use of multiple nucleic acid amplification tests to
define the infected patient “gold standard” in clinical trials of new
diagnostic tests for Chlamydia trachomatis infections. J Clin Microbiol
42(10):4749-4758, 2004.
Ferris MJ, Masztal A, Martin DH. Use of species-directed 16S
rRNA gene PCR primers for detection of Atopobium vaginae in patients with
bacterial vaginosis. J Clin Microbiol 42(12)5892-5894, 2004.
Wang SA, Papp JR, Stamm WE, Peeling RW, Martin DH, Holmes KK.
Evaluation of antimicrobial resistance and treatment failures for Chlamydia
trachomatis: a meeting report. J Infect Dis 191:917-923, 2005.
Schachter J, Hook EW, Martin DH, Willis D, Chernesky M, Fine
P, Fuller D, Jordan J, Janda W. and Hook EW. Confirming positive NAATs for
Chlamydia trachomatis: All NAATs are not created equal. J Clin Microbiol
43(3):1372-1373, 2005.
Marrazzo JM, Johnson RE, Green TA, Stamm WE, Schachter J,
Bolan G, Hook EW III, Jones RB, Martin DH, St. Louis ME, Black CM. Impact of Patient Characteristics on
Performance of Nucleic Acid Amplification Tests and DNA Probe for Chlamydia
trachomatisGenital Infection in Women. J Clin Microbiol (in press).
Martin DH, Nsuami M, Schachter J, Hook EW, III, Ferrero D,
Quinn TC, Gaydos C. Optimizing the Use of Nucleic Acid Amplification Tests to
Define the Infected Patient Standard in Clinical Trials of New Diagnostic Tests
for Chlamydia trachomatis Infections. Submitted for publication.
Kissinger P, Dumestre J, Clark RA, Wenthold L, Mohammed H,
Hagensee ME, Martin DH. Vaginal swabs versus lavage for detection of
Trichomonas vaginalis and bacterial vaginosis among HIV-positive women. Sex
Transm Dis (in press).
Chernesky MA, Hook EW, Martin DH, Lane J, Johnson R, Jordan J, Fuller D, Willis D, Fine P, Janda W, and Schachter. Women find it easy and prefer to collect their own vaginal swabs which are effective for the diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae. Submitted for publication. (JAMA)
Schachter J, Chernesky MA, Willis DE, Fine PM, Martin DH, Fuller D, Jordan J, Janda W, and Hook EW. Vaginal swabs are the specimens of choice when screening for Chlamydia trachomatis and Neisseria gonorrhoeae: Results from a multicenter evaluation of the APTIMA assays for both infections. Submitted for publication. (JAMA).